E72.50 Disorder of glycine metabolism, unspecified

Name of the Condition

• Disorder of glycine metabolism, unspecified (ICD-10 Code: E72.50)

Summary

Disorder of glycine metabolism, unspecified is a rare genetic condition affecting the body’s ability to process glycine, a non-essential amino acid involved in protein synthesis, neurotransmission, and metabolic pathways. This disorder disrupts normal glycine metabolism, leading to abnormal accumulation or deficiency of glycine or its byproducts. Clinical effects vary but may involve neurological, hepatic, or renal impairment, depending on the underlying defect.

Causes

These disorders are primarily caused by genetic mutations that impair enzymes or transport proteins involved in glycine metabolism. Most are inherited in an autosomal recessive pattern, requiring two mutated copies of a gene for the condition to manifest. The mutations disrupt biochemical pathways, resulting in abnormal glycine levels or toxic byproduct accumulation.

Risk Factors

• Family history of glycine metabolism disorders.
• Consanguinity (parents who are close relatives) increasing the likelihood of inheriting recessive mutations.
• Ethnic or geographic prevalence of specific genetic variants in certain populations.

Symptoms

• Neurological symptoms such as developmental delays, seizures, or intellectual disability.
• Gastrointestinal issues like vomiting, poor feeding, or failure to thrive.
• Hepatic or renal dysfunction.
• Muscle weakness or hypotonia.
• Abnormal movements or ataxia.

Diagnosis

Diagnosis involves clinical evaluation, biochemical testing to measure glycine levels in blood or urine, and genetic testing to identify mutations. Additional tests may include imaging studies to assess neurological or organ involvement. A definitive diagnosis requires correlation of clinical findings with laboratory and genetic results.

Treatment Options

Treatment is supportive and may include dietary modifications to manage glycine levels, medications to control seizures or other symptoms, and therapies to address developmental delays. Management is tailored to the individual’s specific manifestations and may involve a multidisciplinary team.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the disorder and the effectiveness of treatment. Regular follow-up with healthcare providers is essential to monitor symptoms, adjust therapies, and address complications. Early intervention may improve outcomes for some individuals.

Complications

• Neurological impairment, including intellectual disability or seizures.
• Hepatic or renal dysfunction.
• Growth failure or nutritional deficiencies.
• Respiratory complications in severe cases.

Lifestyle & Prevention

• Genetic counseling for families with a history of glycine metabolism disorders.
• Avoidance of triggers that may exacerbate symptoms, as advised by healthcare providers.
• Adherence to prescribed dietary or medical management plans.

When to Seek Professional Help

Seek medical attention if symptoms such as seizures, developmental delays, or severe gastrointestinal issues occur. Prompt evaluation is important for early diagnosis and management.

Tips for Medical Coders

When coding for E72.50, ensure documentation supports the unspecified nature of the disorder. Include details on clinical presentation, diagnostic findings, and management to justify the code. Verify that no more specific glycine metabolism disorder is documented, as E72.50 is used when the condition is not further specified.